转移性乳腺癌特异性免疫疗法联合化疗。一项前瞻性随机研究
[Specific immunotherapy in metastasizing breast cancer combined with chemotherapy. A prospective randomized study].
作者信息
Graninger W, Bettelheim P, Jakesz R, Rainer H, Moser K, Mörz R, Miksche M
出版信息
Acta Med Austriaca Suppl. 1979;6:322-4.
PMID:299220
Abstract
40 patients with metastasized mamma carcinoma were immunized with T-antigen, in addition to cytostatic therapy. A second group of 40 patients received cytostatics only. No improvement of remission rates could be obtained by additional immunotherapy with T-antigen.
摘要
40例转移性乳腺癌患者在进行细胞抑制疗法的同时接受了T抗原免疫治疗。另一组40例患者仅接受细胞抑制剂治疗。通过T抗原进行额外的免疫治疗并不能提高缓解率。
Zotero 插件